Navigation Links
Fifth U.S. Hand Transplant Patient Heads Home to NY
Date:2/17/2009

LOUISVILLE, Ky., Feb. 17 /PRNewswire-USNewswire/ -- The United States' fifth hand transplant recipient, Jan "Erik" Hondusky, is heading back home to Massena, New York this week after a three-month stay in Louisville under the care of Kleinert Kutz and University of Louisville surgeons.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090217/DC71832)

Kleinert Kutz and UofL hand surgeons performed the Hondusky's hand transplant at Louisville's Jewish Hospital Hand Care Center on November 24, 2008, during a record nine-hour surgical procedure. Warren C. Breidenbach, M.D., with Kleinert Kutz and University of Louisville assistant clinical professor of surgery, led the team of five hand surgeons, 10 hand fellows and a two-member anesthesiology team from Hand Care Center Anesthesia.

"I cannot wait to get home and pick up my granddaughter with two hands and give big two-handed hugs to all my family and friends, said Hondusky. "This has been an awesome event in my life and I have made many new friends here in Louisville. I cannot thank everyone enough -- the doctors, nurses, therapists, donor family and others who have helped me here in Louisville."

The New York resident is a 43-year-old production worker who injured his dominant right hand in a furnace accident on April 12, 2006, when his hand was crushed and burned thus requiring amputation. He used a prosthetic hand to perform daily living activities before the transplant procedure.

Lead hand transplant surgeon Dr. Breidenbach said, "Erik continues to work on mobility exercises and strengthening the muscle groups in the hand and arm using light weights. Functional activities for grasping, releasing and pinching continue to improve, as well. He can perform such daily living activities as washing his hair with both hands, holding a phone with his new right hand, shaking hands in greeting, opening a door, writing with a pen, grasping a water bottle, throwing and bouncing a ball, and picking up objects three inches wide. He can lift a bucket weighing 12 pounds with his right hand and a 20 pound crate with two hands." Hondusky will continue therapy three times week after returning home.

Kadiyala Ravindra, M.D., University of Louisville assistant professor of surgery, who manages the anti-rejection drug therapy for Hondusky said, "Erik has had a few mild rejection episodes over the past three months, which were not surprising, and we were able to treat each with medication. He is doing remarkably well and we expect him to continue to do so."

Hondusky received one dose of Campath, an immunosuppressive medication, during surgery and is on mono-therapy -- one drug for most of the past three months. Maintaining a patient on one drug as opposed to two or three, reduces the risk of rejection. Risks associated with immunosuppressive drugs include a higher incidence of cancer, infections and other disorders.

"Reducing the number of drugs a patient is on will continue to reduce the risks associated with hand transplantation and we believe we can achieve this with our patients going forward," said Ravindra. "We will also continue to monitor him very closely for signs of rejection with biopsies and other laboratory tests."

A hand transplant, unlike a solid organ transplant, involves multiple tissues (skin, muscle, tendon, bone, cartilage, fat, nerves and blood vessels) and is called composite tissue allotransplantation.

A partnership of physicians and researchers at Jewish Hospital Hand Care Center, Kleinert Kutz and the University of Louisville developed the pioneering procedure. Breidenbach and his team are the only surgeons to perform hand transplants in the U.S. To date, there have been a total of 40 hands transplanted on 32 patients around the world.

Kentuckiana Organ Donor Affiliates (KODA) worked very closely with the Indiana Organ Procurement Organization to coordinate the hand donation with the family and hospital. Without the help of these organ procurement agencies and the family, this procedure could not have taken place.

The fifth U.S. hand transplant is sponsored by the Department of Defense, Office of Naval Research and Office of Army Research to further research in the composite tissue allotransplantation program.

Information, photography and video are available on our web sites at www.handtransplant.com and www.jewishhospital.org. Video on the website is not broadcast quality.


'/>"/>
SOURCE Jewish Hospital
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center
2. Dominos Pizza Pledges Support to the Fifth Annual St. Jude Childrens Research Hospital(R) Thanks and Giving(R) Campaign
3. Aegera Initiates a Fifth Phase 1 and 2 Clinical Trial for AEG35156
4. Fifth DSMB Meeting Supports Neurobiological Technologies Continuation of Phase 3 Stroke Trials With Viprinex(TM) (ancrod)
5. ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
6. Cleveland Clinic Surgeons Perform Nations First Near-Total Face Transplant
7. Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients
8. Research Explores the Effects of Stem Cell Source and Patient Age on Stem Cell Transplantation Outcomes
9. Kiadis Pharma Announces Positive Clinical Results for ATIR(TM) in Mismatched Bone Marrow Transplantations
10. American Heart Association Journal Report: Miniaturized Heart Pumps May Be Effective for Children Awaiting Transplant
11. Pediatric Heart Transplants at Montefiore Approved by NY State Department of Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Dublin ... of the " Global Markets for Spectroscopy Equipment" ... This report focuses on the global ... including its applications in various applications. The report deals ... three main industries: pharmaceutical and biotechnology, food and beverage, ...
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016 /PRNewswire/ ... pulmonary function testing company, is now able to perform sophisticated lung ... ndd Medical Technologies , Inc. Patients are ... labs.  Thanks to ndd,s EasyOne PRO ® , ARL patients like ... any needed testing done in the comfort of her own home. ...
(Date:6/24/2016)... , Belgium , June 24, ... VNRX), today announced the appointment of Dr. ... Directors as a Non-Executive Director, effective June 23, ... Audit, Compensation and Nominations and Governance Committees.  As ... Futcher will provide independent expertise and strategic counsel ...
Breaking Medicine Technology:
(Date:6/27/2016)... (PRWEB) , ... June 27, ... ... in the patient payment industry today announced its strategic partnership with Connance, ... system workflows. , The two companies’ proven, proprietary technology combine to provide ...
(Date:6/26/2016)... Aliso Viejo, California (PRWEB) , ... June 26, 2016 , ... ... for Final Cut Pro X. , "Film editors can give their videos a whole ... artistically," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Levels ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery ... of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , ... for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
Breaking Medicine News(10 mins):